AU1052795A - Compositions and methods for transduction of cells - Google Patents

Compositions and methods for transduction of cells

Info

Publication number
AU1052795A
AU1052795A AU10527/95A AU1052795A AU1052795A AU 1052795 A AU1052795 A AU 1052795A AU 10527/95 A AU10527/95 A AU 10527/95A AU 1052795 A AU1052795 A AU 1052795A AU 1052795 A AU1052795 A AU 1052795A
Authority
AU
Australia
Prior art keywords
transduction
compositions
cells
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10527/95A
Inventor
Laurence H Kedes
Robert A. Kloner
Howard M Prentice
Vittorio Sartorelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southern California USC filed Critical University of Southern California USC
Publication of AU1052795A publication Critical patent/AU1052795A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU10527/95A 1993-11-08 1994-11-08 Compositions and methods for transduction of cells Abandoned AU1052795A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14909893A 1993-11-08 1993-11-08
US149098 1993-11-08
PCT/US1994/012912 WO1995012979A1 (en) 1993-11-08 1994-11-08 Compositions and methods for transduction of cells

Publications (1)

Publication Number Publication Date
AU1052795A true AU1052795A (en) 1995-05-29

Family

ID=22528792

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10527/95A Abandoned AU1052795A (en) 1993-11-08 1994-11-08 Compositions and methods for transduction of cells

Country Status (2)

Country Link
AU (1) AU1052795A (en)
WO (1) WO1995012979A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7238673B2 (en) 1989-03-31 2007-07-03 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US6110459A (en) * 1997-05-28 2000-08-29 Mickle; Donald A. G. Transplants for myocardial scars and methods and cellular preparations
US6099832A (en) 1997-05-28 2000-08-08 Genzyme Corporation Transplants for myocardial scars
IT1299201B1 (en) * 1998-05-08 2000-02-29 San Raffaele Centro Fond GENETICALLY MODIFIED FIBROBLASTS AND THEIR USE
WO1999062940A2 (en) * 1998-05-30 1999-12-09 Collateral Therapeutics, Inc. Methods of altering cardiac cell phenotype
GB2346146A (en) * 1998-08-14 2000-08-02 Univ Texas Calcineurin-dependent control of skeletal muscle fiber type
EP1200559A2 (en) 1999-07-23 2002-05-02 Diacrin, Inc. Muscle cells and their use in cardiac repair
US7547674B2 (en) 2001-06-06 2009-06-16 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US20020061587A1 (en) 2000-07-31 2002-05-23 Piero Anversa Methods and compositions for the repair and/or regeneration of damaged myocardium
US7862810B2 (en) 2000-07-31 2011-01-04 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
WO2002084281A1 (en) 2001-04-13 2002-10-24 Anterogen Co., Ltd. Encapsulated cell indicator system
AU2006244197A1 (en) 2005-05-09 2006-11-16 Mytogen, Inc. Cellular cardiomyoplasty as supportive therapy in patients with heart disease
CA2743184A1 (en) 2007-11-09 2009-05-14 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium using cytokines and variants thereof

Also Published As

Publication number Publication date
WO1995012979A1 (en) 1995-05-18

Similar Documents

Publication Publication Date Title
AU7564694A (en) Erection-inducing methods and compositions
AU7323294A (en) Perfluoroelastomeric compositions and methods
AU7333494A (en) Bitetrazoleamine gas generant compositions and methods of use
AU6268594A (en) Novel silico-titanates and their methods of making and using
IL109008A0 (en) Immunoassy for determination of cells
AU2551997A (en) Compositions and processes for photogeneration of acid
EP0863748A4 (en) Liposomal compositions and methods of using them
AU7524496A (en) Stable avidin composition and methods using same
AU5296596A (en) Composition and method for production of transformed cells
AU1313995A (en) Composition of polyketone and polyolefin
AU4370096A (en) Hydrocarbyl containing coatings, compositions and methods of use
AU1532297A (en) Starch-emulsifier composition and methods of making
AU5979496A (en) Composition and methods for losing weight
AU7294194A (en) Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof
AU2777295A (en) Method of waterproofing wood and associated composition
AU6959694A (en) Antineoplastic compositions and methods of use
AU5872294A (en) Compositions and methods for inhibiting deoxyhypusine synthase and the growth of cells
AU1052795A (en) Compositions and methods for transduction of cells
AU6905894A (en) Trichohyalin and transglutaminase-3 and methods of using same
AU1841195A (en) 1-beta -methyl-carbapenem, compositions containing same and methods of use
AU4468093A (en) Composition and methods for the generation of bone
AU6723294A (en) Use of simmondsine
AU6368394A (en) Polymer-polypeptide composition and method
AU4185296A (en) Mobilisation of haematopoietic cells
AU5077996A (en) Coating compositions and methods of using them